155 related articles for article (PubMed ID: 22985190)
1. Accuracy validation of adjuvant! online in Taiwanese breast cancer patients--a 10-year analysis.
Yao-Lung K; Dar-Ren C; Tsai-Wang C
BMC Med Inform Decis Mak; 2012 Sep; 12():108. PubMed ID: 22985190
[TBL] [Abstract][Full Text] [Related]
2. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
Mook S; Schmidt MK; Rutgers EJ; van de Velde AO; Visser O; Rutgers SM; Armstrong N; van't Veer LJ; Ravdin PM
Lancet Oncol; 2009 Nov; 10(11):1070-6. PubMed ID: 19801202
[TBL] [Abstract][Full Text] [Related]
3. An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.
Campbell HE; Taylor MA; Harris AL; Gray AM
Br J Cancer; 2009 Oct; 101(7):1074-84. PubMed ID: 19724274
[TBL] [Abstract][Full Text] [Related]
4. Underestimated survival predictions of the prognostic tools Adjuvant! Online and PREDICT in BRCA1-associated breast cancer patients.
Plakhins G; Irmejs A; Gardovskis A; Subatniece S; Liepniece-Karele I; Purkalne G; Teibe U; Trofimovics G; Miklasevics E; Gardovskis J
Fam Cancer; 2013 Dec; 12(4):683-9. PubMed ID: 23640109
[TBL] [Abstract][Full Text] [Related]
5. Population-based validation of the prognostic model ADJUVANT! for early breast cancer.
Olivotto IA; Bajdik CD; Ravdin PM; Speers CH; Coldman AJ; Norris BD; Davis GJ; Chia SK; Gelmon KA
J Clin Oncol; 2005 Apr; 23(12):2716-25. PubMed ID: 15837986
[TBL] [Abstract][Full Text] [Related]
6. Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study.
de Glas NA; van de Water W; Engelhardt EG; Bastiaannet E; de Craen AJ; Kroep JR; Putter H; Stiggelbout AM; Weijl NI; van de Velde CJ; Portielje JE; Liefers GJ
Lancet Oncol; 2014 Jun; 15(7):722-9. PubMed ID: 24836274
[TBL] [Abstract][Full Text] [Related]
7. [Adjuvant!Online--an Internet-based decision tool for adjuvant chemotherapy in early breast cancer].
Hess V
Ther Umsch; 2008 Apr; 65(4):201-5. PubMed ID: 18622911
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
9. Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients.
Kuo SH; Lien HC; You SL; Lu YS; Lin CH; Chen TZ; Huang CS
Breast; 2008 Dec; 17(6):646-53. PubMed ID: 18595699
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
11. Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.
Jänicke F; Prechtl A; Thomssen C; Harbeck N; Meisner C; Untch M; Sweep CG; Selbmann HK; Graeff H; Schmitt M;
J Natl Cancer Inst; 2001 Jun; 93(12):913-20. PubMed ID: 11416112
[TBL] [Abstract][Full Text] [Related]
12. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
[TBL] [Abstract][Full Text] [Related]
13. A population-based validation of the prognostic model PREDICT for early breast cancer.
Wishart GC; Bajdik CD; Azzato EM; Dicks E; Greenberg DC; Rashbass J; Caldas C; Pharoah PD
Eur J Surg Oncol; 2011 May; 37(5):411-7. PubMed ID: 21371853
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
15. Application of the adjuvant! Online model to Korean breast cancer patients: an assessment of prognostic accuracy and development of an alternative prognostic tool.
Jung M; Choi EH; Nam CM; Rha SY; Jeung HC; Lee SH; Yang WI; Roh JK; Chung HC
Ann Surg Oncol; 2013 Aug; 20(8):2615-24. PubMed ID: 23543197
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
Ohnstad HO; Borgen E; Falk RS; Lien TG; Aaserud M; Sveli MAT; Kyte JA; Kristensen VN; Geitvik GA; Schlichting E; Wist EA; Sørlie T; Russnes HG; Naume B
Breast Cancer Res; 2017 Nov; 19(1):120. PubMed ID: 29137653
[TBL] [Abstract][Full Text] [Related]
17. Early response to neo-adjuvant chemotherapy in carcinoma of the breast predicts both successful breast-conserving surgery and decreased risk of ipsilateral breast tumor recurrence.
Ishitobi M; Komoike Y; Motomura K; Koyama H; Inaji H
Breast J; 2010; 16(1):9-13. PubMed ID: 19929889
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity to input variability of the Adjuvant! Online breast cancer prognostic model.
Ozanne EM; Braithwaite D; Sepucha K; Moore D; Esserman L; Belkora J
J Clin Oncol; 2009 Jan; 27(2):214-9. PubMed ID: 19047286
[TBL] [Abstract][Full Text] [Related]
19. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer.
Paridaens RJ; Gelber S; Cole BF; Gelber RD; Thürlimann B; Price KN; Holmberg SB; Crivellari D; Coates AS; Goldhirsch A
Breast Cancer Res Treat; 2010 Aug; 123(1):303-10. PubMed ID: 20195744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]